In contrast, Yan et al. [21], Hu et al. [11], and Zhu et al. [112] suggested that the ERCC2 Asp312Asn polymorphism was not associated with breast cancer, head and neck cancer, and skin cancer, respectively. The gene discussed is ERCC2; the disease is breast cancer.